| 英文名稱(chēng) |
中文名稱(chēng) |
CAS號(hào) |
操作 |
| MT189 |
|
1885900-35-5 |
詳細(xì)
|
| Dersimelagon |
|
1835256-48-8 |
詳細(xì)
|
| Befotertinib |
|
1835667-63-4 |
詳細(xì)
|
| Epoxyazadiradione |
|
18385-59-6 |
詳細(xì)
|
| Mukanadin C |
|
1839104-78-7 |
詳細(xì)
|
| Nafoxidine |
|
1845-11-0 |
詳細(xì)
|
| CM-579 |
|
1846570-40-8 |
詳細(xì)
|
| Elamipretide Triacetate |
|
1849610-71-4 |
詳細(xì)
|
| AZD9977 |
|
1850385-64-6 |
詳細(xì)
|
| 1,3,6,8-Tetrahydroxynaphthalene |
|
18512-30-6 |
詳細(xì)
|
| Chimmitecan |
|
185425-25-6 |
詳細(xì)
|
| BTK inhibitor 17 |
|
1858206-76-4 |
詳細(xì)
|
| SU 4981 |
|
186610-88-8 |
詳細(xì)
|
| Eciruciclib |
|
1868086-40-1 |
詳細(xì)
|
| UNC3866 TFA(1872382-47-2 free base) |
|
1872382-48-3 |
詳細(xì)
|
| CM-675 |
|
1872466-47-1 |
詳細(xì)
|
| WH-4-025 |
|
1876463-35-2 |
詳細(xì)
|
| ethyl 2-[3,5-bis(trifluoromethyl)phenyl]-3-oxo-2,3-dihydro-1H-pyrazole-4-carboxylate |
|
1878204-21-7 |
詳細(xì)
|
| Pramlintide acetate(151126-32-8 free base) |
|
187887-46-3 |
詳細(xì)
|
| NF-1819 |
|
1881244-28-5 |
詳細(xì)
|
| FFN 102 mesylate |
|
1883548-92-2 |
詳細(xì)
|
| RORγt Inverse agonist 6 |
|
1887161-80-9 |
詳細(xì)
|
| NGB 2904 |
|
189060-98-8 |
詳細(xì)
|
| ABT-080 |
|
189498-57-5 |
詳細(xì)
|
| Abeprazan hydrochloride |
|
1902954-87-3 |
詳細(xì)
|
| PI3Kδ-IN-1 |
|
1911564-39-0 |
詳細(xì)
|
| FCPR03 |
|
1917347-65-9 |
詳細(xì)
|
| RL648_81 |
|
1919050-87-5 |
詳細(xì)
|
| 16beta-Methyl-16alpha,17alpha-epoxypregnenolone |
|
1922-48-1 |
詳細(xì)
|
| BP 897 |
|
192384-87-5 |
詳細(xì)
|
| SK33 |
|
1928724-23-5 |
詳細(xì)
|
| DDR-TRK-1 |
|
1934246-19-1 |
詳細(xì)
|
| (S)-4-methyl-N-(3-(4-methyl-1H-imidazol-1-yl)-5-(trifluoromethyl)phenyl)-2-(pyrimidin-5-yl)-1,2,3,4-tetrahydroisoquinoline-7-carboxamide |
|
1934246-20-4 |
詳細(xì)
|
| MP07-66 |
|
1938056-90-6 |
詳細(xì)
|
| Magnoloside F |
|
1945997-27-2 |
詳細(xì)
|
| EST64454 hydrochloride |
|
1950569-11-5 |
詳細(xì)
|
| 5-phenylthieno[2,3-d]pyrimidin-4-amine |
|
195193-10-3 |
詳細(xì)
|
| ZEN-3862 |
|
1952264-33-3 |
詳細(xì)
|
| 3-phenoxy-8-azabicyclo[3.2.1]octane hydrochloride |
|
1955540-15-4 |
詳細(xì)
|
| CORT-108297 Enantiomer |
|
1956435-30-5 |
詳細(xì)
|
| TAXUSIN |
|
19605-80-2 |
詳細(xì)
|
| PF-04802367 |
|
1962178-27-3 |
詳細(xì)
|
| LCB 03-0110 dihydrochloride |
|
1962928-28-4 |
詳細(xì)
|
| JNJ-DGAT2-A |
|
1962931-71-0 |
詳細(xì)
|
| KDM2B-IN-2 |
|
1965248-01-4 |
詳細(xì)
|
| N-[1-(Aminocarbonyl)-4-[(2-chloro-1-iminoethyl)amino]butyl]benzamide |
|
1965308-76-2 |
詳細(xì)
|
| Coblopasvir dihydrochloride |
|
1966138-53-3 |
詳細(xì)
|
| ARN19702 |
|
1971937-18-4 |
詳細(xì)
|
| GSK3186899 |
|
1972617-87-0 |
詳細(xì)
|
| JAK1-IN-8 |
|
1973485-18-5 |
詳細(xì)
|
| Valiglurax |
|
1976050-09-5 |
詳細(xì)
|
| DL-Willardiine |
|
19772-76-0 |
詳細(xì)
|
| Antiproliferative agent-15 |
|
19819-18-2 |
詳細(xì)
|
| CT-1 |
|
1983924-33-9 |
詳細(xì)
|
| 4-[(2,4-dioxo-1,3-thiazolidin-5-ylidene)methyl]benzoic acid |
|
199167-79-8 |
詳細(xì)
|
| [Des-Arg9]-Bradykinin TFA |
|
199433-70-0 |
詳細(xì)
|
| WAY-311677 |
|
19948-85-7 |
詳細(xì)
|
| ROCK2-IN-2 |
|
1995065-79-6 |
詳細(xì)
|
| SMARCA-BD ligand 1 for Protac |
|
1997319-92-2 |
詳細(xì)
|
| GNE-064 |
|
1997321-20-6 |
詳細(xì)
|
| BMS986260 |
|
2001559-19-7 |
詳細(xì)
|
| PHD-1-IN-1 |
|
2009343-14-8 |
詳細(xì)
|
| Hydroxyisogermafurenolide |
|
20267-91-8 |
詳細(xì)
|
| hDHODH-IN-5 |
|
2029049-77-0 |
詳細(xì)
|
| 123C4 |
|
2034159-30-1 |
詳細(xì)
|
| AMPA receptor modulator-2 |
|
2034181-36-5 |
詳細(xì)
|
| Oritinib |
|
2035089-28-0 |
詳細(xì)
|
| AMPA receptor modulator-1 |
|
2036074-41-4 |
詳細(xì)
|
| ICCB280 |
|
2041072-41-5 |
詳細(xì)
|
| CDK9 inhibitor HH1 |
|
204188-41-0 |
詳細(xì)
|
| AZD9898 |
|
2042347-69-1 |
詳細(xì)
|
| Cevidoplenib dimesylate |
|
2043659-93-2 |
詳細(xì)
|
| P-gp inhibitor 1 |
|
2050747-49-2 |
詳細(xì)
|
| PDGFR Tyrosine Kinase Inhibitor III |
|
205254-94-0 |
詳細(xì)
|
| KN1022 |
|
205255-11-4 |
詳細(xì)
|
| CT52923 |
|
205256-55-9 |
詳細(xì)
|
| MNK8 |
|
2055078-49-2 |
詳細(xì)
|
| MPT0B390 |
|
1817802-18-8 |
詳細(xì)
|
| Ubiquitination-IN-1 |
|
1819330-15-8 |
詳細(xì)
|
| MSP3 |
|
1820968-63-5 |
詳細(xì)
|
| HIV-1 inhibitor-6 |
|
1821309-39-0 |
詳細(xì)
|
| EM-651 |
|
182167-58-4 |
詳細(xì)
|
| Ataquimast |
|
182316-31-0 |
詳細(xì)
|
| GDC-0214 |
|
1831144-46-7 |
詳細(xì)
|
| MLT-943 |
|
1832576-04-1 |
詳細(xì)
|
| Ascorbyl Propyl Hyaluronate |
|
1800464-57-6 |
詳細(xì)
|
| ICCB-19 hydrochloride |
|
1803605-68-6 |
詳細(xì)
|
| WCK-4234 sodium |
|
1804915-68-1 |
詳細(xì)
|
| CPFX4158 |
|
1804962-84-2 |
詳細(xì)
|
| Tyrosinase-IN-2 |
|
180864-33-9 |
詳細(xì)
|
| ERCC1-XPF-IN-2 |
|
1808986-37-9 |
詳細(xì)
|
| (Rac)-EC5026 |
|
1809885-55-9 |
詳細(xì)
|
| YCN47284 |
|
181147-28-4 |
詳細(xì)
|
| MAP4K4-IN-3 |
|
1811510-58-3 |
詳細(xì)
|
| Cabozantinib hydrochloride |
|
1817759-42-4 |
詳細(xì)
|
| Bevurogant |
|
1817773-66-2 |
詳細(xì)
|
| CJ-13,610 hydrochloride |
|
179420-27-0 |
詳細(xì)
|
| 3-(2,6-dichlorophenyl)-1-methyl-7-(methylsulfanyl)-1H,2H,3H,4H-pyrimido[4,5-d][1,3]diazin-4-one |
|
1799561-19-5 |
詳細(xì)
|
| AZ044 |
|
1800017-49-5 |
詳細(xì)
|
| DHODH-IN-1 |
|
1800296-63-2 |
詳細(xì)
|